Navega Therapeutics

San Diego, United States

Navega Therapeutics is a preclinical stage company developing epigenetic gene therapies for neurological and ophthalmic diseases.

Feb 2025

Grant

Biopharma Biotechnology Health Care Neuroscience Therapeutics

Top Investors

Creative Destruction LabCalifornia Institute for Regenerative MedicineNational Cancer InstituteNational Institute of Neurological Disorders and Stroke

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Navega Therapeutics

Who are Navega Therapeutics's investors?

Navega Therapeutics's investors include Creative Destruction Lab, California Institute for Regenerative Medicine, National Cancer Institute, National Institute of Neurological Disorders and Stroke.

Where is Navega Therapeutics headquartered?

Navega Therapeutics is headquartered in San Diego, United States.

What does Navega Therapeutics do?

Navega Therapeutics is a preclinical stage company developing epigenetic gene therapies for neurological and ophthalmic diseases.

What stage is Navega Therapeutics at?

Navega Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 4, 2025.

MLA

"Navega Therapeutics — Funding & Investors." VCBacked, February 4, 2025, https://www.vcbacked.co/company/navega-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2025). Navega Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/navega-therapeutics

Wikipedia (cite web)

{{cite web |title=Navega Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/navega-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 4, 2025.